zolpidem has been researched along with Cognition Disorders in 8 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Triazolam was associated with longer total sleep time and increased Stage 2 sleep." | 1.36 | Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. ( Kehne, JH; Malison, RT; Morgan, PT; Sprenger, KJ, 2010) |
| " Performance testing and subjective evaluations occurred prior to dosing and following forced awakening at 15:00, 2 h after dosing." | 1.34 | Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep. ( Cardenas, R; Eddy, DR; Fischer, J; Hickey, PA; Storm, WF; Welch, CB, 2007) |
| "Zolpidem is a GABA (A) agonist, which is indicated for the short-term management of insomnia." | 1.33 | Abnormal auditory N400 in a case of zolpidem dependence, during a working memory test. ( Liappas, IA; Papageorgiou, CC; Rabavilas, AD, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buysse, DJ | 1 |
| Morgan, PT | 1 |
| Kehne, JH | 1 |
| Sprenger, KJ | 1 |
| Malison, RT | 1 |
| Hall, SD | 1 |
| Yamawaki, N | 1 |
| Fisher, AE | 1 |
| Clauss, RP | 1 |
| Woodhall, GL | 1 |
| Stanford, IM | 1 |
| Cotroneo, A | 2 |
| Gareri, P | 2 |
| Lacava, R | 2 |
| Cabodi, S | 2 |
| Liappas, IA | 1 |
| Papageorgiou, CC | 1 |
| Rabavilas, AD | 1 |
| Hindmarch, I | 1 |
| Legangneux, E | 1 |
| Stanley, N | 1 |
| Emegbo, S | 1 |
| Dawson, J | 1 |
| Storm, WF | 1 |
| Eddy, DR | 1 |
| Welch, CB | 1 |
| Hickey, PA | 1 |
| Fischer, J | 1 |
| Cardenas, R | 1 |
| Nicoletti, N | 1 |
| Grassone, D | 1 |
| Maina, E | 1 |
| De Sarro, G | 1 |
2 trials available for zolpidem and Cognition Disorders
| Article | Year |
|---|---|
Use of zolpidem in over 75-year-old patients with sleep disorders and comorbidities.
Topics: Aged; Cognition Disorders; Comorbidity; Diabetes Mellitus; Female; Health Status; Humans; Hypertensi | 2004 |
A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.
Topics: Adult; Aged; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics | 2006 |
6 other studies available for zolpidem and Cognition Disorders
| Article | Year |
|---|---|
Toward optimal health: diagnosis and management of disordered sleep in women: Dr. Daniel J Buysse interviewd by Jodi R. Godfrey.
Topics: Behavior Therapy; Cognition Disorders; Comorbidity; Female; Health Status; Humans; Hypnotics and Sed | 2009 |
Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
Topics: Adult; Arousal; Cognition Disorders; Disorders of Excessive Somnolence; Dose-Response Relationship, | 2010 |
GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report.
Topics: Biological Clocks; Cognition Disorders; Evoked Potentials, Somatosensory; GABA Agonists; Humans; Mag | 2010 |
Abnormal auditory N400 in a case of zolpidem dependence, during a working memory test.
Topics: Adult; Cognition Disorders; Evoked Potentials, Auditory; Female; GABA Agonists; Humans; Memory Disor | 2006 |
Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep.
Topics: Adjuvants, Immunologic; Adult; Circadian Rhythm; Clinical Trials as Topic; Cognition; Cognition Diso | 2007 |
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status | 2007 |